Immunohistochemical Expression in Male Breast Cancer: Two Case Reports

Kaohsiung Journal of Medical Sciences

Kun-Bow Tsai¹  Shih-Wen Hu¹  Je-Hen Chuang² 

[1] Department of Pathology Kaohsiung, Taiwan;Division of Gastroenterology and General Surgery, Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan;

关键词: male breast cancer;    p53;    Ki-67;    HER-2/neu;    Bcl-2;   

DOI  :  10.1016/S1607-551X(09)70242-6

来源: DOAJ

【 摘 要 】

Male breast cancer is rare, and the incidence is less than 1% of all breast malignancies in both men and women. It is possible that, because male patients are unaware of male breast cancer, there is a delay of diagnosis and, consequently, more advanced stages are commonly encountered in these patients. Some studies have engaged in molecular studies of male breast cancers because of the possibly different characteristics, prognosis, and treatment between male and female malignancies. However, a dearth of studies still exists, most likely because of the rarity of the disease and lack of a large patient base for study. Among the molecular markers of breast cancer, p53, Ki-67, HER-2/neu, and Bcl-2 are the most frequently studied. Here we present two rare cases and a review of the literature concerning the relationship between immunohistochemical markers and their impact in order to provide surgeons with more information about the disease and further techniques for treatment of these patients.

【 授权许可】

Unknown